Skip to main content

KBC Group NV

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1411133 Brussels, C9

Position in TEVA

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$1,669,069
-$60,401 QoQ
Shares Held
55,414
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

KBC Group NV holds $69,833,201 across 25 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 TEVA
Teva Pharmaceutical Industries Ltd
This page
55,414 $1,669,069

All Filings in TEVA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,669,069 55,414
2025-12-31 $1,729,470 55,414
2025-09-30 $1,119,362 55,414
2025-06-30 $928,738 55,414
2025-03-31 $721,098 46,916
2024-12-31 $819,072 37,163
2024-09-30 $467,492 25,943
2024-06-30 $421,573 25,943
2024-03-31 $366,055 25,943
2023-12-31 $158,792 15,210
2023-09-30 $218,035 21,376
2023-06-30 $160,961 21,376
2023-03-31 $112,819 12,748
2022-12-31 $116,261 12,748
2022-09-30 $102,876 12,748
2022-06-30 $95,864 12,748
2022-03-31 $119,703 12,748
2021-12-31 $102,111 12,748
2021-09-30 $394,382 40,491
2021-06-30 $262,171 26,482
2021-03-31 $305,602 26,482
2020-12-31 $255,551 26,482
2020-09-30 $238,602 26,482
2020-06-30 $326,523 26,482
2020-03-31 $430,186 47,905